358 related articles for article (PubMed ID: 36330148)
1. Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis.
Wu Q; Chen Z; Ding Y; Tang Y; Cheng Y
Front Nutr; 2022; 9():1033129. PubMed ID: 36330148
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of ferroptosis in nonalcoholic fatty liver disease and therapeutic effects of traditional Chinese medicine: a review.
Wang N; Que H; Luo Q; Zheng W; Li H; Wang Q; Gu J
Front Med (Lausanne); 2024; 11():1356225. PubMed ID: 38590315
[TBL] [Abstract][Full Text] [Related]
3. Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.
Zhou Z; Zhang J; You L; Wang T; Wang K; Wang L; Kong X; Gao Y; Sun X
Front Endocrinol (Lausanne); 2022; 13():1000727. PubMed ID: 36204095
[TBL] [Abstract][Full Text] [Related]
4. Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies.
Ding X; He X; Tang B; Lan T
Chin Med; 2024 Feb; 19(1):21. PubMed ID: 38310315
[TBL] [Abstract][Full Text] [Related]
5. An overview of ferroptosis in non-alcoholic fatty liver disease.
Wang S; Liu Z; Geng J; Li L; Feng X
Biomed Pharmacother; 2022 Sep; 153():113374. PubMed ID: 35834990
[TBL] [Abstract][Full Text] [Related]
6. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease.
Zhou H; Ma C; Wang C; Gong L; Zhang Y; Li Y
Eur J Pharmacol; 2021 May; 898():173976. PubMed ID: 33639194
[TBL] [Abstract][Full Text] [Related]
7. Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease.
Sui Y; Geng X; Wang Z; Zhang J; Yang Y; Meng Z
Metabolism; 2024 Jun; 157():155953. PubMed ID: 38885833
[TBL] [Abstract][Full Text] [Related]
8. Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review.
Zheng S; Xue C; Li S; Zao X; Li X; Liu Q; Cao X; Wang W; Qi W; Zhang P; Ye Y
Front Pharmacol; 2024; 15():1381712. PubMed ID: 38694920
[TBL] [Abstract][Full Text] [Related]
9. Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies.
Zhang H; Zhang E; Hu H
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829889
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of ferroptosis on chronic kidney disease and traditional Chinese medicine intervention: a review].
Yang BY; Liu X; Hu S; Peng YJ; Zhang WN; Liu BL; He ZY
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2629-2639. PubMed ID: 38812163
[TBL] [Abstract][Full Text] [Related]
11. [Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease].
Yuan XW; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):262-267. PubMed ID: 38584112
[TBL] [Abstract][Full Text] [Related]
12. TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination.
Zhang J; Xie H; Yao J; Jin W; Pan H; Pan Z; Xie D; Xie D
Hum Cell; 2023 Jan; 36(1):209-222. PubMed ID: 36417114
[TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives.
Dai X; Feng J; Chen Y; Huang S; Shi X; Liu X; Sun Y
Chin Med; 2021 Aug; 16(1):68. PubMed ID: 34344394
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications.
Cheng Z; Chu H; Zhu Q; Yang L
Front Nutr; 2023; 10():1090338. PubMed ID: 36992907
[TBL] [Abstract][Full Text] [Related]
16. Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine.
Shao M; Lu Y; Xiang H; Wang J; Ji G; Wu T
Front Pharmacol; 2022; 13():971561. PubMed ID: 36091827
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
Feng G; Byrne CD; Targher G; Wang F; Zheng MH
Liver Int; 2022 Jul; 42(7):1496-1502. PubMed ID: 35007392
[TBL] [Abstract][Full Text] [Related]
18. The Gut Microbiome and Ferroptosis in MAFLD.
Ji J; Wu L; Wei J; Wu J; Guo C
J Clin Transl Hepatol; 2023 Feb; 11(1):174-187. PubMed ID: 36406312
[TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.
Liu C; Liao JZ; Li PY
World J Gastroenterol; 2017 Mar; 23(11):1964-1973. PubMed ID: 28373762
[TBL] [Abstract][Full Text] [Related]
20. Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease.
Zhao S; Guo Y; Yin X
Front Biosci (Landmark Ed); 2023 Dec; 28(12):332. PubMed ID: 38179745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
